Avadel Pharmaceuticals plc(US:AVDL) Globenewswire·2025-11-05 16:10Key Information - The discloser is Avadel Pharmaceuticals plc, which is the offeree in relation to its relevant securities [2][4] - The position was held as of November 4, 2025 [2] - There are no interests or short positions disclosed for the relevant securities [4] Interests and Short Positions - No relevant securities owned or controlled by the discloser [4] - No cash-settled or stock-settled derivatives reported [4] - Total interests and short positions are NIL [4] Interests of Persons Acting in Concert - Total interests held by directors of Avadel Pharmaceuticals plc amount to 794,959 ordinary shares, representing 0.81% of the total issued ordinary share capital [6] - The total number of underlying stock options and other rights held by these directors is 4,347,557 [6] Other Information - No indemnity or other dealing arrangements were reported [9] - No agreements or arrangements relating to options or derivatives were disclosed [9] - A Supplemental Form 8 is not attached [10]